170 related articles for article (PubMed ID: 34513994)
21. Effects of Animal Strain, Dose, and Cotreatment with Saikosaponin b
Fu R; Liu J; Xue Y; Zhang Z; Song R
Eur J Drug Metab Pharmacokinet; 2019 Dec; 44(6):827-836. PubMed ID: 31317503
[TBL] [Abstract][Full Text] [Related]
22. Differential toll-like receptor 3 (TLR3) expression and apoptotic response to TLR3 agonist in human neuroblastoma cells.
Chuang JH; Chuang HC; Huang CC; Wu CL; Du YY; Kung ML; Chen CH; Chen SC; Tai MH
J Biomed Sci; 2011 Aug; 18(1):65. PubMed ID: 21861882
[TBL] [Abstract][Full Text] [Related]
23. Suppressing effect of saikosaponin A, an active ingredient of Bupleurum falcatum, on chocolate self-administration and reinstatement of chocolate seeking in rats.
Lorrai I; Maccioni P; Carai MA; Capra A; Castelli MP; Riva A; Morazzoni P; Gessa GL; Colombo G
Neurosci Lett; 2017 Jan; 638():211-217. PubMed ID: 28007642
[TBL] [Abstract][Full Text] [Related]
24. Saikosaponin a inhibits RANKL-induced osteoclastogenesis by suppressing NF-κB and MAPK pathways.
Zhou C; Liu W; He W; Wang H; Chen Q; Song H
Int Immunopharmacol; 2015 Mar; 25(1):49-54. PubMed ID: 25617149
[TBL] [Abstract][Full Text] [Related]
25. Saikosaponin D from Radix Bupleuri suppresses triple-negative breast cancer cell growth by targeting β-catenin signaling.
Wang J; Qi H; Zhang X; Si W; Xu F; Hou T; Zhou H; Wang A; Li G; Liu Y; Fang Y; Piao HL; Liang X
Biomed Pharmacother; 2018 Dec; 108():724-733. PubMed ID: 30248540
[TBL] [Abstract][Full Text] [Related]
26. Saikosaponin A Inhibits LPS-Induced Endometritis in Mice Through Activating Nrf2 Signaling Pathway.
Wang J; Wang W; Pang Y
Inflammation; 2018 Aug; 41(4):1508-1514. PubMed ID: 29748729
[TBL] [Abstract][Full Text] [Related]
27. Saikosaponin d induces cell death through caspase-3-dependent, caspase-3-independent and mitochondrial pathways in mammalian hepatic stellate cells.
Chen MF; Huang SJ; Huang CC; Liu PS; Lin KI; Liu CW; Hsieh WC; Shiu LY; Chen CH
BMC Cancer; 2016 Jul; 16():532. PubMed ID: 27461108
[TBL] [Abstract][Full Text] [Related]
28. Recognition and identification of active components from Radix Bupleuri using human neuroblastoma SH-SY5Y cells.
Zhang Y; Liu F; Zhang X; Xu T; Quan W; Wang H; Shi J; Dai Z; Wu B; Wu Q
Biomed Chromatogr; 2016 Mar; 30(3):440-6. PubMed ID: 26194341
[TBL] [Abstract][Full Text] [Related]
29. Saikosaponin a contributed to CCIN treatment by promoting neutrophil bactericidal activity via activation CBL-dependent ERK pathway.
Qi X; Liu J; Li X; Fan M; Huang N; Sun R
Phytomedicine; 2021 Feb; 82():153444. PubMed ID: 33421903
[TBL] [Abstract][Full Text] [Related]
30. Ultrasensitive Time-Resolved Fluoroimmunoassay for Saikosaponin a in Chaihu (Bupleuri Radix).
Chao Z; Cui Q; Tian E; Zeng W; Cai X; Li X; Tanaka H; Shoyama Y; Wu Y
PLoS One; 2016; 11(3):e0151032. PubMed ID: 26968034
[TBL] [Abstract][Full Text] [Related]
31. Oleanen induces apoptosis of cervical cancer cells by up-regulation of Bim.
Gan N; Chen G; Zhang W; Zhou J
Int J Gynecol Cancer; 2012 Jan; 22(1):38-42. PubMed ID: 21897270
[TBL] [Abstract][Full Text] [Related]
32. Saikosaponins and the deglycosylated metabolites exert liver meridian guiding effect through PXR/CYP3A4 inhibition.
Liu Q; Xue Y; Liu J; Ren S; Xu J; Yang J; Xing Y; Zhang Z; Song R
J Ethnopharmacol; 2021 Oct; 279():114344. PubMed ID: 34147617
[TBL] [Abstract][Full Text] [Related]
33. Histone-lysine methyltransferase EHMT2 is involved in proliferation, apoptosis, cell invasion, and DNA methylation of human neuroblastoma cells.
Lu Z; Tian Y; Salwen HR; Chlenski A; Godley LA; Raj JU; Yang Q
Anticancer Drugs; 2013 Jun; 24(5):484-93. PubMed ID: 23466651
[TBL] [Abstract][Full Text] [Related]
34. Antitumor effects of saikosaponin b2 on breast cancer cell proliferation and migration.
Ma Q; Gao FF; He X; Li K; Gao Y; Xu XL; Jiang NH; Ding L; Song WJ; He YQ; Pan WT; Wei L; Zhang JW
Mol Med Rep; 2019 Aug; 20(2):1943-1951. PubMed ID: 31257464
[TBL] [Abstract][Full Text] [Related]
35. Reducing effect of saikosaponin A, an active ingredient of Bupleurum falcatum, on alcohol self-administration in rats: Possible involvement of the GABAB receptor.
Maccioni P; Lorrai I; Carai MAM; Riva A; Morazzoni P; Mugnaini C; Corelli F; Gessa GL; Colombo G
Neurosci Lett; 2016 May; 621():62-67. PubMed ID: 27080427
[TBL] [Abstract][Full Text] [Related]
36. [Study on liver protection and hepatotoxicity of saikosaponin a based on zebrafish model].
Xia Q; Han LW; Zhang Y; He QX; Zhang SS; Gao JJ; Liu KC; Tu PF
Zhongguo Zhong Yao Za Zhi; 2019 Jul; 44(13):2662-2666. PubMed ID: 31359674
[TBL] [Abstract][Full Text] [Related]
37. Development of an assay system for saikosaponin a using anti-saikosaponin a monoclonal antibodies.
Zhu SH; Shimokawa S; Tanaka H; Shoyama Y
Biol Pharm Bull; 2004 Jan; 27(1):66-71. PubMed ID: 14709901
[TBL] [Abstract][Full Text] [Related]
38. Xanthohumol increases death receptor 5 expression and enhances apoptosis with the TNF-related apoptosis-inducing ligand in neuroblastoma cell lines.
Engelsgjerd S; Kunnimalaiyaan S; Kandil E; Gamblin TC; Kunnimalaiyaan M
PLoS One; 2019; 14(3):e0213776. PubMed ID: 30870485
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxicity of Saikosaponin A targets HEKa cell through apoptosis induction by ROS accumulation and inflammation suppression via NF-κB pathway.
Liu M; Zhang G; Naqvi S; Zhang F; Kang T; Duan Q; Wang Z; Xiao S; Zheng Y
Int Immunopharmacol; 2020 Sep; 86():106751. PubMed ID: 32634696
[TBL] [Abstract][Full Text] [Related]
40. Saikosaponin a attenuates lead-induced kidney injury through activating Nrf2 signaling pathway.
Song Y; Sun H; Gao S; Tang K; Zhao Y; Xie G; Gao H
Comp Biochem Physiol C Toxicol Pharmacol; 2021 Apr; 242():108945. PubMed ID: 33278595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
